ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

California Hospital Raises $22 Million For New Cancer Center

September 14, 1990

Biomedical Supercomputer Will Be Available To NIH, Extramural Scientists; No Payback Planned To Starts

July 13, 1984

Retrovirus Vaccination Is Feasible, Workshop Participants Conclude

May 3, 1985

House Committee on Appropriations approves $28.5 billion for NIH.

June 24, 2005

Peter Shields Named Deputy Director At Ohio State

September 16, 2011